AcuCort AB engages in the development, market, and sale of Dexa oral dissolvable films. Its product is primarily for acute allergic reaction, croup, and chemotherapy-induced nausea, and vomiting. The company was founded on November 15, 2006 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company